Jackson O’Brien, Ph.D.Back to team
Dr. O’Brien joined Lincoln Park Capital in 2021 as a biotechnology analyst. Prior to joining, he developed proof-of-principal molecular computational devices to demonstrate and understand the computational capacity of biochemical systems as a graduate researcher at the University of Chicago’s Department of Physics (M.S. in 2017, Ph.D conferral December 2021). During his academic career, he collaborated with interdisciplinary teams of physicists, computer scientists, and chemical/biological engineers on primary research publications and presentations at international conferences. Currently, he covers biotechnology and therapeutics broadly with an emphasis on computational methodologies. He completed a B.S. with a double major in Physics and Mathematics at Butler University in 2016, graduating summa cum laude and Phi Beta Kappa.